FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

11500011000001103: Zentel 200mg chewable tablets (GlaxoSmithKline Australia Pty Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
42220001000001119 Zentel 200mg chewable tablets (GlaxoSmithKline Australia Pty Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
43204701000001113 Zentel 200mg chewable tablets (Imported (Australia)) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zentel 200mg chewable tablets (GlaxoSmithKline Australia Pty Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zentel 200mg chewable tablets (GlaxoSmithKline Australia Pty Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction imported true Inferred relationship Existential restriction modifier
Zentel 200mg chewable tablets (GlaxoSmithKline Australia Pty Ltd) Is a Albendazole 200mg chewable tablets true Inferred relationship Existential restriction modifier
Zentel 200mg chewable tablets (GlaxoSmithKline Australia Pty Ltd) Has active ingredient Albendazole true Inferred relationship Existential restriction modifier
Zentel 200mg chewable tablets (GlaxoSmithKline Australia Pty Ltd) Has manufactured dose form Conventional release chewable tablet false Inferred relationship Existential restriction modifier
Zentel 200mg chewable tablets (GlaxoSmithKline Australia Pty Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zentel 200mg chewable tablets (GlaxoSmithKline Australia Pty Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zentel 200mg chewable tablets (GlaxoSmithKline Australia Pty Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zentel 200mg chewable tablets (GlaxoSmithKline Australia Pty Ltd) Has specific active ingredient Albendazole true Inferred relationship Existential restriction modifier
Zentel 200mg chewable tablets (GlaxoSmithKline Australia Pty Ltd) Has dispensed dose form Conventional release chewable tablet true Inferred relationship Existential restriction modifier
Zentel 200mg chewable tablets (GlaxoSmithKline Australia Pty Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zentel 200mg chewable tablets (GlaxoSmithKline Australia Pty Ltd) Has manufactured dose form Conventional release chewable tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zentel 200mg chewable tablets (GlaxoSmithKline Australia Pty Ltd) 6 tablet Is pack of False Zentel 200mg chewable tablets (GlaxoSmithKline Australia Pty Ltd) Inferred relationship Existential restriction modifier
Zentel 200mg chewable tablets (GlaxoSmithKline Australia Pty Ltd) 6 tablet Has AMP True Zentel 200mg chewable tablets (GlaxoSmithKline Australia Pty Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start